Trulieve Cannabis Corp.
TCNNF
$4.70
$0.358.05%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.94% | 5.07% | 2.77% | 0.21% | -4.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.94% | 5.07% | 2.77% | 0.21% | -4.30% |
| Cost of Revenue | -12.83% | -12.92% | -10.59% | -5.74% | -0.58% |
| Gross Profit | 18.44% | 21.60% | 15.12% | 5.42% | -7.30% |
| SG&A Expenses | 36.26% | 32.19% | 6.31% | -7.64% | -9.06% |
| Depreciation & Amortization | 5.94% | 2.71% | -0.91% | -4.27% | -8.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.71% | 5.54% | -2.99% | -6.33% | -4.82% |
| Operating Income | -29.08% | -0.17% | 109.70% | 92.04% | 0.56% |
| Income Before Tax | 112.25% | 115.01% | 120.72% | 124.66% | -640.93% |
| Income Tax Expenses | 13.59% | 30.54% | 28.12% | 28.02% | 10.05% |
| Earnings from Continuing Operations | 61.53% | 64.47% | 71.74% | 81.74% | -123.81% |
| Earnings from Discontinued Operations | 91.04% | 94.06% | 97.50% | 97.30% | 28.20% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -22.56% | 6.31% | -3.31% | -27.05% | 32.65% |
| Net Income | 66.05% | 70.56% | 77.43% | 85.76% | -74.60% |
| EBIT | -29.08% | -0.17% | 109.70% | 92.04% | 0.56% |
| EBITDA | -11.81% | -1.69% | 24.52% | 23.43% | -3.27% |
| EPS Basic | 66.27% | 70.71% | 77.52% | 85.78% | -74.17% |
| Normalized Basic EPS | -39.33% | 43.67% | 1,142.04% | 597.67% | 11.50% |
| EPS Diluted | 66.27% | 70.71% | 77.52% | 85.78% | -74.17% |
| Normalized Diluted EPS | -39.33% | 43.67% | 1,142.04% | 597.67% | 11.50% |
| Average Basic Shares Outstanding | 0.68% | 0.55% | 0.44% | 0.32% | 0.40% |
| Average Diluted Shares Outstanding | 0.68% | 0.55% | 0.44% | 0.32% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |